publication venue for
- Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome. 2025
- Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.. 31. 2024
- Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.. 31. 2024
- Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis. 2024
- The association of intensive blood pressure treatment and non-fatal cardiovascular or serious adverse events in older adults with mortality: mediation analysis in SPRINT.. 30. 2023
- Burden of cardiovascular disease attributable to particulate matter pollution in the eastern Mediterranean region: analysis of the 1990-2019 global burden of disease.. 30. 2023
- Tooth loss is independently associated with poor outcomes in stable coronary heart disease.. 23. 2015
- A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markers.. 21. 2013
- Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.. 21. 2012
- Cause-specific mortality in diabetes: recent changes in trend mortality.. 19. 2012
- Effect of shift work on endothelial function in young cardiology trainees.. 19. 2011
- Prevalence and outcome of cigarette and waterpipe smoking among patients with acute coronary syndrome in six Middle-Eastern countries.. 19. 2011
- Pregnancy in Women with Turner Syndrome: Balancing Reproductive Advances with Maternal Safety. 2025
- Inflammation in coronary artery disease: Which biomarker and which treatment?. 26. 2019